Universal Health Services (UHS) 2025 Earnings Quality Report

Grade: F — Major Red Flags

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2026-02-25) + Yahoo Finance

Auditor: PricewaterhouseCoopers LLP — Clean opinion (1 Critical Audit Matter)

One-line verdict: Universal Health Services owns 375 inpatient facilities and 168 outpatient facilities across 40 states plus the U.K. and Puerto Rico. Revenue jumped 9.7% to $17.36B and net income climbed 30% to $1.49B, driven by an 8.5% Same-Facility net revenue increase at the acute care hospitals and rate expansion. Three red flags demand attention: cash of $0.1B covers only 3% of $5.2B in debt, goodwill plus intangibles of $4.0B equals 55% of equity, and receivables grew 19.5% — twice the revenue growth rate — pushing DSO from 50 to 55 days as the company booked $145M more in Medicaid supplemental payment receivables. The 10-K explicitly warns that the "One Big Beautiful Budget Act" signed July 4, 2025 will reduce UHS's aggregate annual net benefit from state Medicaid supplemental payment programs "by approximately $432 million to $480 million by 2032" — against a current $1.339B net benefit. The earnings are real, but 8% of net benefit is legislated to disappear in the next decade.

Two Segments, 543 Facilities, Dual Concentration

Per the MD&A: "As of February 25, 2026, we owned and/or operated 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico."

Revenue split per the MD&A:

The 10-K discloses concentration risk with Texas, Nevada, and California:

Three states produce 44% of revenue but 53% of operating income, a concentration the 10-K explicitly flags as sensitivity "to regulatory, economic, public health, environmental and competitive conditions in those states."

Results of Operations: Strong Year, One Caveat

Per the results of operations table in MD&A:

The $134M "Other income" surge is important context. Per the MD&A, it includes "an increase of $93 million from an unrealized gain recorded during 2025 in connection with our minority ownership in a healthcare generative artificial intelligence company" and "an increase of $16 million from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025." That is $109M of non-operating gains — 7% of net income — that may not recur.

Salaries declined as a % of revenue from 47.5% to 46.6%, a key operational win. The MD&A attributes it to "team-based patient care initiatives designed to optimize the level of patient care services provided by our licensed nurses/clinicians" and "efforts to reduce utilization of, and rates paid for, premium pay labor."

Self-insured claims added $45M in reserves in 2025, down from $79M in 2024 — a $34M tailwind.

Cash Flow: Operating Cash Went the Wrong Way

Per the MD&A Liquidity section:

CFFO fell $203M even as net income rose $348M. Per the MD&A: "an unfavorable change of $385 million in accounts receivable (due, in part, to a $145 million increase in net receivables recorded in connection with various Medicaid supplemental payment programs and a $50 million increase in accounts receivable related to two relatively recently opened hospitals in Las Vegas, NV, and Washington, D.C.)."

DSO jumped from 50 days to 55 days. That is a 10% deterioration in collection speed — our A2 watch flag. The Medicaid supplemental receivable balance grew because of timing, but the 10-K is clear: "The increase in net receivables recorded in connection with various Medicaid supplemental payment programs" is the single largest unfavorable cash flow swing.

Per the MD&A, 2025 financing activities included "spent $968 million to repurchase shares of our Class B Common Stock... $899 million open market purchases pursuant to our stock repurchase program" plus "$286 million of proceeds from additional borrowings" including "$278 million pursuant to our revolving credit facility." UHS funded buybacks partly with debt.

Balance Sheet: $0.1B Cash, $5.2B Debt — Highly Levered

The screening engine flags cash of $0.1B against total debt of $5.2B as a critical red flag. Per the MD&A: "Our total debt as a percentage of total capitalization was approximately 40% at each of December 31, 2025 and December 31, 2024."

The 10-K also discloses: "As of December 31, 2025, we had combined aggregate principal of $3.0 billion" in notes alone, including "$700 million aggregate principal amount of the 2026 Notes; $500 million aggregate principal amount of the 2029 Notes; $800 million" of other notes, plus the $1.2 billion term loan A and revolving credit facility borrowings.

Goodwill and intangibles of $4.0B represent 55% of equity — our D1 red flag. UHS is a roll-up of acute care and behavioral health facilities, so goodwill is expected. But the 55% mark means any multi-facility write-down would be material.

Interest expense fell from $186M to $156M (-16%) — a tailwind from refinancing and rate management. Share repurchases of $968M exceeded free cash flow of $849M. The company is returning capital it does not entirely generate.

The Legislative Time Bomb: $432-480M Annual Hit by 2032

From the 10-K MD&A: "Legislation adopted on July 4, 2025 (the One Big Beautiful Budget Act), attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditure. That legislation also places limits on provider fees used to increase federal Medicaid funding to states."

The crucial quantification, also from the MD&A: "Based upon our current 2025 full year net benefit related to various state Medicaid supplemental payment programs, amounting to approximately $1.339 billion, as reflected on the table above in Summary of Various State Medicaid Supplemental Payment Programs, we estimate that, commencing with the 2028 state fiscal years, our aggregate annual net benefit will be reduced, on an annually increasing and relatively pro rata basis, by approximately $432 million to $480 million by 2032."

That is a $432-480M annual hit against $1.994B of 2025 operating income — potentially a 22-24% reduction by 2032. UHS cannot offset it with volume alone. The MD&A lists mitigations including rate negotiations with commercial insurers and productivity programs but offers no specific offset quantification.

Separately, the 10-K flags the expiration of "certain insurance exchange premium tax credits beyond 2025" which "is expected to be adversely impacted" for exchange enrollment. Some uninsured-to-insured mix reversal is baked in.

The 18-Point Screening

Beneish M-Score components:

The DSRI of 1.09 aligns with the AR growth watch flag. No single score crosses the manipulation threshold.

Key Risks from the 10-K

1. Medicaid Reform — Quantified $432-480M Annual Headwind

Per Item 1A Risk Factors: "Legislation adopted on July 4, 2025 (the One Big Beautiful Budget Act), attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditure."

And: "We estimate that, commencing with the 2028 state fiscal years, our aggregate annual net benefit will be reduced, on an annually increasing and relatively pro rata basis, by approximately $432 million to $480 million by 2032."

2. Geographic Concentration

Per Item 1A: "A significant portion of our revenue is produced by facilities located in Texas, Nevada and California." The 10-K warns: "This geographic concentration makes us particularly sensitive to regulatory, economic, public health, environmental and competitive conditions in those states... certain of our facilities and our operations in those states may be adversely impacted by wildfires (most particularly in California), winter storms, and other severe weather conditions, which adverse weather conditions may be more frequent and/or severe as the result of climate change."

3. Litigation Exposure

Per Item 1A, the 10-K names specific outstanding matters: "the jury verdict returned against Cumberland Hospital for Children and Adolescents located in New Kent, Virginia, an indirect subsidiary of ours, and the verdict in the Pinnacle litigation in Washoe County, Nevada, against certain subsidiaries of ours."

The MD&A adds: "Effective March, 2025, our excess commercial insurance coverage for professional and general liability claims contains less favorable terms than previous years including coverage exclusions for incidents involving sexual molestation or abuse, higher premiums and lower aggregate limitations." That is a notable insurance retreat.

4. Labor, Wage Inflation, and Physician Shortages

Per Item 1A: "Our success depends in part upon our ability to recruit and retain quality physicians... The loss of one or more of these physicians, even if temporary, could cause a material reduction in our revenues." 2025 saw UHS reduce salaries as % of revenue from 47.5% to 46.6% — a tailwind that management explicitly attributed to "efforts to reduce utilization of, and rates paid for, premium pay labor," but wage inflation pressure persists.

5. Cybersecurity Attacks on Healthcare Providers

Per the 10-K: "There is a heightened risk of future cybersecurity threats, including ransomware attacks targeting healthcare providers. If successful, future cyberattacks could have a material adverse effect on our business." The industry has seen high-profile hospital ransomware attacks; UHS itself was hit by a major ransomware incident in 2020 (referenced elsewhere in the filing).

6. Medicare DSH Reductions Starting 2028

Per the 10-K: "Beginning in federal fiscal year 2028, the Medicaid disproportionate share hospital ( DSH ) allotment to the states from federal funds will be reduced." UHS's acute care hospitals serve significant Medicaid populations that depend on DSH supplemental payments.

Auditor's Critical Audit Matter: Valuation of Accounts Receivable

PwC flagged accounts receivable valuation as its sole Critical Audit Matter: "As described in Notes 1 and 10 to the consolidated financial statements, the Company reports net patient service revenue at the estimated net realizable amounts from patients and third-party payers and others for services rendered... Estimates of contractual allowances, which represent explicit price concessions, under managed care plans are based upon the payment terms specified in the related contractual agreements. Management estimates Medicare and Medicaid revenues using the latest available financial information, patient utilization data, government provided data..."

The choice of CAM is significant. PwC did not flag self-insurance reserves (despite the liability coverage reduction), or goodwill impairment, or legal contingencies. The only matter deemed "especially challenging, subjective, or complex" was revenue estimation from third-party payers — which is also exactly where DSO deteriorated 10% year-over-year. The two signals point in the same direction.

Key Financial Trends (3-Year)

Summary

Grade: F. The business is running hot; the balance sheet and legislative outlook are thin.

UHS had a strong operational 2025 — revenue up 9.7%, operating income up 18.6%, net income up 30%. The Altman Z-Score of 3.61 is solidly in the safe zone and PwC issued an unqualified opinion. This is not a company anywhere close to distress.

But the screening framework reveals three reasons to investigate further:

The legislative risk dwarfs everything else. The MD&A volunteered a remarkable quantification: annual net benefit from Medicaid supplemental payment programs will fall by $432-480M by 2032, against a current $1.339B net benefit. That is roughly 24% of 2025 operating income legislated to disappear. Mitigation via rate negotiation, productivity, and mix shift is possible but is not quantified in the filing.

Yellow flags:

What would change our view: DSO stabilizing back toward 50 days, an explicit mitigation plan for the Medicaid supplemental program reductions, and a reduction in buyback-by-debt.

**Disclaimer**: This report is based on Universal Health Services' fiscal year 2025 10-K filed with the SEC on February 25, 2026. This is NOT investment advice.

**About EarningsGrade**: We screen earnings reports for financial red flags using an 18-point forensic framework. Grade F means major red flags were detected that warrant thorough investigation.